Overview of CJC-1295 with DAC

CJC-1295 with DAC is a synthetic modified version of Growth Hormone Releasing Hormone (GHRH). The critical ‘with DAC’ designation refers to the Drug Affinity Complex — a maleimide group that covalently binds to serum albumin after injection, dramatically extending the peptide’s half-life from minutes (native GHRH) to approximately 6-8 days. This allows twice-weekly research dosing protocols.

Each vial available from SteroidsCanada.is contains 2mg of lyophilized CJC-1295 with DAC, manufactured to rigorous pharmaceutical-grade standards and independently verified for purity exceeding 99% via HPLC analysis. This makes it an ideal choice for qualified researchers and laboratory professionals seeking dependable, high-quality peptides for gh releasing hormone research applications.

Mechanism of Action

Once injected, CJC-1295 DAC binds to serum albumin via its DAC modification, protecting it from enzymatic degradation by dipeptidyl peptidase IV (DPP-IV). The albumin-bound peptide then slowly releases and continuously binds to GHRH receptors in the anterior pituitary, stimulating enhanced pulsatile growth hormone release that follows the body’s natural circadian rhythm.

Key Research Applications

Product Specifications

Reconstitution Guidelines

CJC-1295 with DAC is supplied as a lyophilized (freeze-dried) powder that must be reconstituted with sterile bacteriostatic water (0.9% benzyl alcohol) before use in research applications. The recommended reconstitution volume for this vial is 2mL of bacteriostatic water, which yields a concentration suitable for precise research dosing.

Reconstitution Math — Quick Reference

If you add 2mL of bacteriostatic water to this 2mg vial:

On a standard 100 IU insulin syringe, here’s what each measurement equals for research reference:

Reconstitution Best Practices

• Use sterile bacteriostatic water (0.9% benzyl alcohol preservative)
• Add diluent slowly along the vial wall — never directly onto the peptide cake
• Gently swirl to dissolve — never shake the vial vigorously
• Allow the peptide to fully dissolve before drawing any dose
• Store reconstituted vials at 2–8°C (refrigerator)
• Use reconstituted peptide within 28–60 days depending on specific research requirements
• Always use sterile technique when drawing from the reconstituted vial

Research Protocol Guidelines

Research commonly uses 100-300mcg 2-3x weekly, often combined with Ipamorelin for synergistic GHRH+GHRP mechanism studies.

Typical Research Timeline

• Week 1-2: Initial IGF-1 elevation in research models
• Week 3-6: Peak GH axis adaptation research phase
• Week 7-12: Sustained IGF-1 research plateau
• Week 13-16: Extended research applications

Individual research results vary based on protocol design, specific research objectives, and research model characteristics. The above timeline represents commonly observed patterns in published research literature.

Research Stacking Protocols

In research applications, CJC-1295 with DAC is often studied in combination with complementary research peptides to investigate pathway interactions. Common research combinations include:

• CJC-1295 DAC + Ipamorelin: Gold-standard GH research combo
• CJC-1295 DAC + BPC-157: GH axis + tissue repair research
• CJC-1295 DAC + Tesamorelin: Advanced GHRH research

Any research stacking protocol should be designed based on specific investigative objectives and informed by current scientific literature.

Why Choose SteroidsCanada.is?

• ✅ Pharmaceutical-grade CJC-1295 with DAC — lab tested for purity and potency
• ✅ Discreet shipping across Canada — plain outer packaging always
• ✅ Proper cold-chain handling to preserve peptide integrity
• ✅ Same-day dispatch on orders placed before 2PM EST
• ✅ COA available on request for every batch and SKU
• ✅ Secure payment — Interac E-Transfer and cryptocurrency
• ✅ Free shipping on all orders over $600 CAD
• ✅ Competitive Canadian pricing with no hidden fees
• ✅ Responsive customer service and reliable restocking